Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 1, 2025 $203.44 -0.90% $206.27 X 98.63% 2
Apr 1, 2025 $206.45 +0.56% $206.27 V 99.91% 9
Apr 1, 2025 $193.29 -5.85% $206.27 X 93.71% 1
Mar 3, 2025 $207.41 -0.78% $211.48 X 98.07% 0
Mar 3, 2025 $208.01 -0.49% $211.48 X 98.36% 0
Mar 3, 2025 $209.03 +0.00% $211.48 X 98.84% 1
Mar 3, 2025 Bullish $211.48 V 1
Feb 20, 2025 $195.73 -0.82% $200.88 X 97.44% 0
Feb 20, 2025 $196.34 -0.51% $200.88 X 97.74% 0
vlamanchev vlamanchev Amateur
Feb 20, 2025 Bullish $200.88 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE